A team of researchers at McMaster University is working on an inhaled COVID-19 vaccine that offers better protection and is less costly to produce, store and ship.
Because inhaled vaccines target the lungs and upper airways where respiratory viruses first enter the body, they are far more effective at inducing a protective immune response, the researchers report.
Vaccines developed at McMaster target the lungs first.
McMaster logo
McMaster logo
